These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2839625)

  • 1. Increase in plasma ouabainlike inhibitor of Na+, K+-ATPase with high sodium intake in patients with essential hypertension.
    Hasegawa T; Masugi F; Ogihara T; Kumahara Y
    J Clin Hypertens; 1987 Dec; 3(4):419-29. PubMed ID: 2839625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal sodium handling and sodium transport inhibitor in salt-sensitive essential hypertension.
    Iwaoka T; Umeda T; Miura F; Inoue J; Sasaki M; Naomi S; Sato T
    J Hypertens; 1991 Jan; 9(1):49-54. PubMed ID: 1848259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of the Na, K-ATPase inhibitor in renal sodium handling in patients with essential hypertension].
    Komura H; Kikuchi K; Nozawa A; Hasegawa T; Suzuki S; Yamamoto M; Satoh N; Ohtomo T; Takada T; Iimura O
    Nihon Jinzo Gakkai Shi; 1989 Jul; 31(7):775-81. PubMed ID: 2555614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Presence and regulation of plasma with natriuretic and Na-K ATPase inhibitory properties in normotensive subjects].
    Krzesinski JM; Potier JP; Godon JP; Rorive GL
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):960-5. PubMed ID: 2821949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormonal profile and participation of nitric oxide in salt-sensitive and salt-resistant essential arterial hypertension].
    Gómez-Fernández P; Moreno VG; Cornejo M; Vargas JC; García-Barroso C; Velasco G; Almaraz M
    Nefrologia; 2000; 20(5):415-23. PubMed ID: 11100662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of renal Na+, K+-ATPase: the possible novel mechanism of leptin-induced hypertension.
    Bełtowski J; Jamroz-Wiśniewska A; Borkowska E; Wójcicka G
    Pol J Pharmacol; 2004; 56(2):213-22. PubMed ID: 15156072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of salt intake on endothelium-derived factors in a group of patients with essential hypertension.
    Bragulat E; de la Sierra A; Antonio MT; Jiménez W; Urbano-Márquez A ; Coca A
    Clin Sci (Lond); 2001 Jul; 101(1):73-8. PubMed ID: 11410117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of vascular Na,K-ATPase activity in salt induced hypertension in Dahl rats.
    Vasdev S; Prabhakaran VM; Fernandez P; Sampson C
    Res Commun Chem Pathol Pharmacol; 1988 Oct; 62(1):79-91. PubMed ID: 2849788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biochemical approach of a circulating Na+-pump inhibitor.
    Devynck MA; de The H; Pernollet MG; Cloix JF; Rosenfeld JB; Kamal LA; Meyer P
    J Physiol (Paris); 1984; 79(6):538-41. PubMed ID: 6152634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic dietary sodium overload and release of a circulating Na+-K+ pump inhibitor].
    Wauquier I; Guicheney P; Delva P; Grichois ML; Devynck MA
    Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1716-9. PubMed ID: 3006622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium, Na+-K+ pump inhibitor and low-renin hypertension.
    Haddy FJ
    Clin Invest Med; 1987 Nov; 10(6):547-54. PubMed ID: 2831002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium-potassium pump inhibitor in the mechanism of one-kidney, one wrap hypertension in dogs.
    Pamnani MB; Swindall BT; Schooley JF; Ghai R; Haddy FJ
    Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):115-21. PubMed ID: 10099845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forearm vasoconstrictor response to ouabain: studies in patients with mild and moderate essential hypertension.
    Hulthén UL; Bolli P; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S75-81. PubMed ID: 6204162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Circulating inhibitor of the Na+-K+ pump in essential hypertension. Physiological and pharmacological variations].
    Pernollet MG; de Thé H; Delva P; Wauquier I; Devynck MA; Baudouin-Legros M; Deray G; Rosenfeld J; Meyer P
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1283-7. PubMed ID: 6098238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salt, Na+,K+-ATPase and hypertension.
    Jaitovich A; Bertorello AM
    Life Sci; 2010 Jan; 86(3-4):73-8. PubMed ID: 19909757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytochemical demonstration of an endogenous inhibitor of Na-K ATPase and its relationship to familial arterial hypertension].
    de Wardener H
    Nephrologie; 1987; 8(1):3-6. PubMed ID: 3035398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Circulating inhibitor of sodium active transport in essential hypertension and volemic expansion].
    Devynck MA; Pernollet MG; Deray G; Rieu M; Meyer P
    Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1691-5. PubMed ID: 3006621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors determining sodium chloride sensitivity of patients with essential hypertension: evaluation by multivariate analysis.
    Oshima T; Matsuura H; Kido K; Matsumoto K; Shingu T; Otsuki T; Inoue I; Kajiyama G
    J Hypertens; 1989 Mar; 7(3):223-7. PubMed ID: 2708819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relation of the natriuretic hormone to essential hypertension.
    de Wardener HE; MacGregor GA
    Postgrad Med J; 1983; 59 Suppl 2():74-7. PubMed ID: 6310538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant difference in the effect of acute saline loading on plasma Na-K ATPase inhibitor and blood pressure between children and adults with essential hypertension.
    Uchiyama M; Sakai K
    Nihon Jinzo Gakkai Shi; 1992 Jan; 34(1):91-7. PubMed ID: 1317474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.